10 February 2005
Newspaper: Diario de Navarra

This year the recently-created company Digna Biotech will invest more than half a million euros in the development of the first seven patents achieved in the Centro de Investigación Médica Aplicada (CIMA) of the Universidad de Navarra.

The company specifically aims to develop and market the discoveries made in the laboratories of the CIMA. As the General Manager of Digna Biotech, Pablo Ortiz, explains, "in this way we want to complete the loop of the cycle of biomedical research carried out in the Universidad de Navarra".